Metraipolis › archive › dc_54cb63d665cb

Long-term monthly mesenchymal stromal cell therapy for advanced chronic lung allograft dysfunction: a single-centre safety and feasibility cohort study — Europe PMC PMID:42807397

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42807397
DOI
10.3389/fmed.2026.1942517
License (as archived)
solo-consultazione
Archived
2026-10-08T17:18:21.159Z
SHA-256 of the archived text
07a3126e55a268b9e0c87acee5c11b427ec3251c9088e32c91a7cb5f33ba8d13
Stable URL of this page
https://metraipolis.com/documento/dc_54cb63d665cb

How to cite

Long-term monthly mesenchymal stromal cell therapy for advanced chronic lung allograft dysfunction: a single-centre safety and feasibility cohort study — Europe PMC PMID:42807397 — Europe PMC (en), https://europepmc.org/article/MED/42807397 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54cb63d665cb (Metraipolis archive dc_54cb63d665cb, sha256 07a3126e55a268b9e0c87acee5c11b427ec3251c9088e32c91a7cb5f33ba8d13)
BibTeX
@misc{dc54cb63d665cb,
  title = {Long-term monthly mesenchymal stromal cell therapy for advanced chronic lung allograft dysfunction: a single-centre safety and feasibility cohort study — Europe PMC PMID:42807397},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42807397},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54cb63d665cb; sha256 07a3126e55a268b9e0c87acee5c11b427ec3251c9088e32c91a7cb5f33ba8d13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807397. Agents can read the archived copy with the MCP tool read_document.